|
Amgen breaks ground on next-generation biomanufacturing plant in Rhode Island
|
02 August 2018 |
|
Amgen and MBC Biolabs announce winners of the Amgen Golden Ticket
|
12 July 2018 |
|
Amgen and Novartis present new data demonstrating long-term efficacy, safety and tolerability of Aimovig TM (erenumab-aooe) in patients with chronic and episodic migraine
|
28 June 2018 |
|
Amgen, Oklahoma Health Care Authority and University of Oklahoma's Pharmacy Management Consultants partner to improve medicaid outcomes
|
11 June 2018 |
|
Amgen Foundation and Harvard team up to offer free online science education platform
|
30 May 2018 |
|
Amgen and Novartis announce expanded collaboration with Banner Alzheimer's Institute in pioneering prevention program
|
03 November 2017 |
|
Amgen and CytomX Therapeutics announce strategic collaboration in immuno-oncology
|
03 October 2017 |
|
Amgen and Simcere announce strategic collaboration to co-develop and commercialize biosimilars in China
|
27 September 2017 |
|
Amgen Foundation pledges up to $5 million to Hurricane Maria relief efforts
|
25 September 2017 |
|
Amgen and Humana partner for improved health outcomes and efficiency
|
22 August 2017 |
|
Repatha® (evolocumab) phase 3 cognitive function study results published in the New England Journal of Medicine
|
16 August 2017 |
|
Amgen and Array BioPharma announce preclinical license and collaboration agreement in inflammation
|
18 July 2017 |
|
Amgen and QB3@953 announce winners of The Amgen Golden Ticket
|
11 July 2017 |
|
Amgen showcases a legacy of science, innovation and collaboration in Cambridge
|
02 June 2017 |
|
Landmark outcomes study shows that Repatha® (Evolocumab) decreases LDL-C to unprecedented low levels and reduces risk of cardiovascular events
|
17 March 2017 |
|
Amgen announces Repatha® (evolocumab) significantly reduced the risk of cardiovascular events in FOURIER outcomes study
|
03 February 2017 |
|
Amgen and Immatics enter strategic collaboration to develop novel bispecific cancer immunotherapies
|
11 January 2017 |
|
Amgen builds its digital health capabilities through investment in leading digital health incubator
|
25 October 2016 |
|
Amgen and Arrowhead Pharmaceuticals announce two cardiovascular collaborations
|
29 September 2016 |
|
Amgen obtains global development and commercial rights from Boehringer Ingelheim for investigational BiTE® immuno-oncology drug for multiple myeloma
|
01 September 2016 |